AZ194 is a first-in-class, orally active inhibitor of CRMP2-Ubc9 interaction and inhibitor of NaV1.7 (IC50=1.2 µM). AZ194 blocks SUMOylation of CRMP2 to selectively reduce the amount of surface-expressed NaV1.7. Antinociceptive effects[1].
Molecular Weight:
567.63
Purity:
99.83
CAS Number:
[2241651-99-8]
Formula:
C34H31F2N3O3
Target:
Sodium Channel
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
